Study evaluates treatment interventions for severe obesity in adolescents

Adolescents with severe obesity who received meal-replacement therapy plus financial incentives experienced a greater reduction in body mass index compared to those who received meal replacement therapy alone, according to

Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic

Drug combination reduces breast cancer risk and improves metabolic health in rats

Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider preventative medication, such as the commonly prescribed